Related Experiment Video
Updated: Nov 29, 2025

Primary Tumor and MEF Cell Isolation to Study Lung Metastasis
Published on: May 20, 2015
Primary tumor and metastasis-sectioning the different steps of the metastatic cascade
1Institute of Pathology, Medical University of Graz, Graz, Austria.
Abstract:
Patients with lung cancer in the majority die of metastases. Treatment options include surgery, chemo- and radiotherapy, targeted therapy by tyrosine kinase inhibitors (TKIs), and immuno-oncologic treatment. Despite the success with these treatment options, cure of lung cancer is achieved in only a very small proportion of patients. In most patients' recurrence and metastasis will occur, and finally kill the patient. Metastasis is a multistep procedure. It requires a change in adhesion of tumor cells for detachment from their neighboring cells. The next step is migration either as single cells [epithelial-mesenchymal transition (EMT)], or as cell clusters (hybrid-EMT or bulk migration). A combination of genetic changes is required to facilitate migration. Then tumor cells have to orient themselves along matrix proteins, detect oxygen concentrations, prevent attacks by immune cells, and induce a tumor-friendly switch of stroma cells (macrophages, myofibroblasts, etc.). Having entered the blood stream tumor cells need to adapt to shear stress, avoid being trapped by coagulation, but also use coagulation in small veins for adherence to endothelia, and express homing molecules for extravasation. Within a metastatic site, tumor cells need a well-prepared niche to establish a metastatic focus. Tumor cells again have to establish a vascular net for maintaining nutrition and oxygen supply, communicate with stroma cells, grow out and set further metastases. In this review the different steps will be discussed with a focus on pulmonary carcinomas. The vast amount of research manuscripts published so far are not easy to analyze: in most reports' single steps of the metastatic cascade are interpreted as evidence for the whole process; for example, migration is interpreted as evidence for metastasis. In lung cancer most often latency periods are shorter, in between 1-5 years. In other cases, despite widespread migration occurs, tumor cells die within the circulation and do not reach a metastatic site. Therefore, migration is a requisite, but does not necessarily predict metastasis. The intention of this review is to point to these different aspects and hopefully provoke research directed into a more functional analysis of the metastatic process.
Insights
Lung cancer metastasis is a complex, multi-step process. Understanding each stage, from cell detachment to forming new tumors, is crucial for developing effective treatments beyond current options.
Area of Science:
- Oncology
- Cell Biology
- Cancer Metastasis Research
Background:
- Lung cancer patients frequently succumb to metastases, despite advances in surgery, chemotherapy, radiotherapy, targeted therapy (TKIs), and immunotherapy.
- Current treatments offer cure for a small fraction, with recurrence and metastasis being common causes of mortality.
- Metastasis is a complex cascade involving tumor cell detachment, migration (epithelial-mesenchymal transition or collective migration), and adaptation to various physiological barriers.
Purpose of the Study:
- To provide a comprehensive review of the metastatic cascade in pulmonary carcinomas.
- To highlight the limitations of current research that often analyzes single steps of metastasis in isolation.
- To emphasize the need for functional analyses of the entire metastatic process to improve therapeutic strategies.
Main Methods:
- Review of existing research manuscripts on cancer cell metastasis.
- Analysis of the distinct stages of the metastatic cascade, including adhesion changes, migration, intravasation, survival in circulation, extravasation, and colonization.
- Focus on pulmonary carcinomas and their specific metastatic behaviors.
Main Results:
- Metastasis involves intricate steps: detachment, migration (EMT, collective), adaptation to circulation (shear stress, coagulation), extravasation, and niche preparation at the metastatic site.
- Migration, while necessary, does not always predict successful metastasis, as tumor cells can perish in circulation.
- Latency periods for lung cancer metastasis are often shorter (1-5 years) compared to other cancers.
Conclusions:
- Effective treatment of lung cancer requires a deeper understanding of the entire metastatic cascade, not just individual steps like migration.
- Further research should focus on functional analyses of the complete metastatic process to identify new therapeutic targets.
- Addressing the complexities of metastasis is key to improving survival rates for lung cancer patients.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

